Pharma R&D return on investment falls to eight-year low; FDA approves Pfizer’s biosimilar to J&J’s Remicade; Novartis to downsize generics business
FDA approves first nebulized LAMA COPD treatment; more than 2,000 cancer immunotherapies in development; FDA issues 3D-printing guidance
As digital-health funding increases, here’s how VR, nanotechnology, and 3D printing could potentially improve the value of healthcare.
MM+M is proud to announce the fourth annual Pinnacle Awards program, which celebrates the medical marketing industry’s most venerable marketers, strategists and creators.
Get the most out of
Register for free and enjoy unlimited access to:
